HKSTP Leads 22 Hong Kong Tech Firms to Global Medtech Show MEDICA 2026
Thestandard · 1 SOURCESabout 3 hours ago2 MIN
Summary
The Hong Kong Science and Technology Parks Corporation (HKSTP) is leading a landmark inaugural delegation of 22 life and health technology enterprises to MEDICA 2026, the world's premier medtech trade fair in Düsseldorf, Germany from November 16 to 19. In partnership with the Hong Kong Trade Development Council (HKTDC), these homegrown innovations will be showcased across five critical healthcare domains: minimally invasive and surgical robotics, advanced orthopedic implants and biomaterials, ophthalmic surgery and vision care, cancer early screening, and non-invasive health management and monitoring .
Key Points
- HKSTP leads 22 top-tier Hong Kong life and health tech firms and university partners to MEDICA 2026 in Düsseldorf, Germany from November 16 to 19
- The delegation operates from the Hong Kong Pavilion and major exhibition zones, presenting world-first breakthrough medical solutions across five domains
- Five innovation domains: surgical robotics, orthopedic implants and biomaterials, ophthalmic surgery, cancer early screening, and health monitoring
- Eyebright Medical, headquartered in Hong Kong Science Park since early 2024, brings MDR-certified products targeting Germany, France, Italy, and Switzerland
- Ms. Zhou Yuxi, General Manager of Eyebright Medical (Hong Kong), will showcase ophthalmic innovations and newly integrated Delta Medical sports medicine business
Why It Matters
This inaugural delegation marks a strategic push to position Hong Kong as an international hub for life and health innovation, actively expanding homegrown medtech solutions into the European market while consolidating partnerships with clinical professionals across core markets .
This inaugural delegation marks a strategic push to position Hong Kong as an international hub for life and health innovation, actively expanding homegrown medtech solutions into the European market while consolidating partnerships with clinical professionals across core markets .